(Q46395870)

English

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

scientific article published on 31 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

0 references

revascularization

1 reference

based on heuristic

inferred from title

object named as

Carlo di Mario

14

0 references

object named as

William Wijns

12

0 references

Marie-Claude Morice

13

object named as

Marie-Claude Morice

1 reference

Europe PubMed Central

21 December 2017

Stephan Windecker

1

object named as

Stephan Windecker

1 reference

Europe PubMed Central

21 December 2017

Patrick W Serruys

2

object named as

Patrick W Serruys

1 reference

Europe PubMed Central

21 December 2017

4

object named as

Pawel Buszman

1 reference

Europe PubMed Central

21 December 2017

20

object named as

Peter Jüni

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

Gerrit-Anne van Es

18

object named as

Gerrit-Anne van Es

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

Robert Jan M van Geuns

16

object named as

Robert-Jan van Geuns

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

10

object named as

Franz Eberli

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

6

object named as

Axel Linke

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

Thomas Ischinger

8

object named as

Thomas Ischinger

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

9

object named as

Volker Klauss

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

17

object named as

Pedro Eerdmans

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

3

object named as

Simon Wandel

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

Stanisław Trznadel

5

object named as

Stanislaw Trznadel

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

7

object named as

Karsten Lenk

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

11

object named as

Roberto Corti

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

author name string

Simon Davies

15

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

Bernhard Meier

19

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

language of work or name

0 references

publication date

31 August 2008

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

372

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

9644

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

1163-1173

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Unanswered questions--drug-eluting stents and the risk of late thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Interval estimation for the difference between independent proportions: comparison of eleven methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes and complications associated with off-label and untested use of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Surrogates, substudies, and real clinical end points in trials of drug-eluting stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus-eluting versus uncoated stents in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical impact of in-stent late loss after drug-eluting coronary stent implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961244-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(08)61244-1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18765162

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46395870&oldid=2109607910"